+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cell Therapy Market by Therapy Type, Cell Source, End User, Application, Therapeutic Areas - Global Forecast to 2030- Product Image
Stem Cell Therapy Market by Therapy Type, Cell Source, End User, Application, Therapeutic Areas - Global Forecast to 2030- Product Image
Sale

Stem Cell Therapy Market by Therapy Type, Cell Source, End User, Application, Therapeutic Areas - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336434
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The stem cell therapy market is rapidly evolving as advances in cell technologies, regulatory alignment, and industry collaboration drive the emergence of new therapeutic options. Senior decision-makers require clear, data-driven foresight to navigate growth opportunities, understand competitive positioning, and guide resource allocation in this dynamic sector.

Market Snapshot: Stem Cell Therapy Market Trends

The Stem Cell Therapy Market grew from USD 4.45 billion in 2024 to USD 5.08 billion in 2025. It is expected to continue growing at a CAGR of 14.33%, reaching USD 9.95 billion by 2030. This expansion reflects increasing investment across biotechnology, clinical research, and commercial manufacturing, propelled by major advances in regenerative applications. Leading markets are scaling operations and diversifying portfolios, responding to strong demand for advanced treatment modalities and robust innovation pipelines.

Scope & Segmentation

This report provides comprehensive coverage of the global stem cell therapy landscape, with deep segmentation for actionable clarity.

  • Therapy Types: Allogeneic therapy, Autologous therapy
  • Cell Sources: Adult stem cells (including hematopoietic, mesenchymal, neural), Embryonic stem cells, Induced pluripotent stem cells, Perinatal stem cells (amniotic fluid, placental, umbilical cord)
  • End Users: Academic and research institutions, Biotechnology and pharmaceutical companies, Hospitals and specialty clinics
  • Applications: Drug discovery and development, Regenerative medicine, Tissue engineering
  • Therapeutic Areas: Cardiovascular diseases, Hematology, Musculoskeletal disorders, Neurological disorders, Oncology
  • Regions: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Analyzed: Anterogen, Astellas Pharma, Beike Biotechnology, BrainStorm Cell Therapeutics, Bristol-Myers Squibb, CellProthera, Fate Therapeutics, Gamida Cell, Garuda Therapeutics, Holostem Terapie Avanzate, Jasper Therapeutics, JCR Pharmaceuticals, Juvena Therapeutics, Kangstem Biotech, Kite Pharma by Gilead Sciences, Lonza Group, Medeze Group, Merck KGaA, Mesoblast, Novo Nordisk, Plasticell, ReNeuron Group, SQZ Biotechnologies by Stemcell Technologies, Takara Bio, Thermo Fisher Scientific, U.S. Stem Cell, Umoja Biopharma, Vericel Corporation

Key Takeaways

  • Regenerative medicine and tissue engineering remain top drivers, as stakeholders pursue solutions for complex chronic and acute conditions across multiple therapeutic categories.
  • Strategic partnerships between academic research, biotech firms, and established pharmaceutical companies are facilitating translational breakthroughs, progressing novel therapy candidates rapidly into clinical settings.
  • Adoption rates are highest in regions with supportive regulatory environments and strong funding infrastructure, encouraging multinational collaboration and technology transfer.
  • Emergence of innovative cell processing platforms and bioengineering advances is facilitating production scalability and improving product consistency, supporting commercialization goals.
  • Supply chain flexibility and standardized approaches to cell manufacturing are increasingly critical for operational resilience and mitigating quality risks.
  • Cross-industry collaborations—such as integrating smart sensors and data analytics into manufacturing—are enhancing quality control, regulatory compliance, and clinical confidence.

Tariff Impact: Navigating 2025 US Policy Dynamics

The 2025 introduction of new US tariffs on key stem cell therapy supply inputs, including specialized reagents and bioreactors, is prompting re-evaluation of supplier networks and domestic sourcing strategies. While these measures may temporarily increase operational costs, they could also stimulate domestic manufacturing innovation and long-term supply stability. Stakeholders are monitoring ongoing policy adjustments and are developing contingency plans to ensure uninterrupted research and commercial progress.

Methodology & Data Sources

This report's findings combine quantitative assessments from public and proprietary databases with insights gathered through expert interviews, peer-reviewed publications, and systematic review of regulatory filings. Data cross-validation ensures robust and objective analysis spanning technologies, market drivers, and emerging regulatory dynamics.

Why This Report Matters

  • Enables data-driven decision-making for strategy, investment, and partnership selection in the stem cell therapy market.
  • Offers targeted competitive intelligence to benchmark innovation, operational models, and global positioning.
  • Provides clarity on supply chain trends and regulatory adaptation for improved risk management.

Conclusion

The stem cell therapy market represents a pivotal opportunity for growth, innovation, and healthcare transformation. Strategic alignment across R&D, manufacturing, and partnership models will shape future market leadership and adoption trajectories.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stem Cell Therapy Market, by Therapy Type
8.1. Introduction
8.2. Allogeneic Therapy
8.3. Autologous Therapy
9. Stem Cell Therapy Market, by Cell Source
9.1. Introduction
9.2. Adult Stem Cells
9.2.1. Hematopoietic Stem Cells
9.2.2. Mesenchymal Stem Cells
9.2.3. Neural Stem Cells
9.3. Embryonic Stem Cells
9.4. Induced Pluripotent Stem Cells
9.5. Perinatal Stem Cells
9.5.1. Amniotic Fluid Stem Cells
9.5.2. Placental Stem Cells
9.5.3. Umbilical Cord Stem Cells
10. Stem Cell Therapy Market, by End User
10.1. Introduction
10.2. Academic & Research Institutions
10.3. Biotechnology & Pharmaceutical Companies
10.4. Hospitals & Specialty Clinics
11. Stem Cell Therapy Market, by Application
11.1. Introduction
11.2. Drug Discovery and Development
11.3. Regenerative Medicine
11.4. Tissue Engineering
12. Stem Cell Therapy Market, by Therapeutic Areas
12.1. Introduction
12.2. Cardiovascular Diseases
12.3. Hematology
12.4. Musculoskeletal Disorders
12.5. Neurological Disorders
12.6. Oncology
13. Americas Stem Cell Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Stem Cell Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Stem Cell Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Anterogen Co., Ltd.
16.3.2. Astellas Pharma Inc.
16.3.3. Beike Biotechnology Co., Ltd.
16.3.4. BrainStorm Cell Therapeutics Inc.
16.3.5. Bristol-Myers Squibb Company
16.3.6. CellProthera SAS
16.3.7. Fate Therapeutics, Inc.
16.3.8. Gamida Cell Ltd.
16.3.9. Garuda Therapeutics
16.3.10. Holostem Terapie Avanzate S.r.l.
16.3.11. Jasper Therapeutics, Inc.
16.3.12. JCR Pharmaceuticals Co., Ltd.
16.3.13. Juvena Therapeutics Inc.
16.3.14. Kangstem Biotech Co., Ltd.
16.3.15. Kite Pharma, Inc. by Gilead Sciences, Inc.
16.3.16. Lonza Group AG
16.3.17. Medeze Group
16.3.18. Merck KGaA
16.3.19. Mesoblast Ltd.
16.3.20. Novo Nordisk A/S
16.3.21. Plasticell
16.3.22. ReNeuron Group PLC
16.3.23. SQZ Biotechnologies Company by Stemcell Technologies
16.3.24. Takara Bio Inc.
16.3.25. Thermo Fisher Scientific Inc.
16.3.26. U.S. Stem Cell Inc
16.3.27. Umoja Biopharma
16.3.28. Vericel Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. STEM CELL THERAPY MARKET MULTI-CURRENCY
FIGURE 2. STEM CELL THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. STEM CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STEM CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STEM CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STEM CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEURAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMNIOTIC FLUID STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PLACENTAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STEM CELL THERAPY MARKET SIZE, BY UMBILICAL CORD STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STEM CELL THERAPY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 54. CANADA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 55. CANADA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 56. CANADA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 95. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. GERMANY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 102. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 104. FRANCE STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. FRANCE STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 116. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 117. ITALY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 118. ITALY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 119. ITALY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 120. ITALY STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ITALY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 123. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SPAIN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 151. DENMARK STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. DENMARK STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 165. QATAR STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 166. QATAR STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 167. QATAR STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 168. QATAR STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 169. QATAR STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. QATAR STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. QATAR STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. FINLAND STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FINLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 194. EGYPT STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 195. EGYPT STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EGYPT STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. EGYPT STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 200. TURKEY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 201. TURKEY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 202. TURKEY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. TURKEY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. TURKEY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NORWAY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NORWAY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 221. POLAND STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 223. POLAND STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 224. POLAND STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 225. POLAND STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. POLAND STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. POLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. CHINA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 244. CHINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 245. CHINA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 246. CHINA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 247. CHINA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. CHINA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. CHINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 250. INDIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 252. INDIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 253. INDIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 254. INDIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. INDIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. INDIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 257. JAPAN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 258. JAPAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. JAPAN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. JAPAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 285. THAILAND STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 286. THAILAND STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 287. THAILAND STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. THAILAND STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. THAILAND STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 327. STEM CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 328. STEM CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Stem Cell Therapy market report include:
  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • Beike Biotechnology Co., Ltd.
  • BrainStorm Cell Therapeutics Inc.
  • Bristol-Myers Squibb Company
  • CellProthera SAS
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd.
  • Garuda Therapeutics
  • Holostem Terapie Avanzate S.r.l.
  • Jasper Therapeutics, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Juvena Therapeutics Inc.
  • Kangstem Biotech Co., Ltd.
  • Kite Pharma, Inc. by Gilead Sciences, Inc.
  • Lonza Group AG
  • Medeze Group
  • Merck KGaA
  • Mesoblast Ltd.
  • Novo Nordisk A/S
  • Plasticell
  • ReNeuron Group PLC
  • SQZ Biotechnologies Company by Stemcell Technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • U.S. Stem Cell Inc
  • Umoja Biopharma
  • Vericel Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.95 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Stem Cell Therapy for Premature Ovarian Failure Market by Cell Type, Therapy Type, End User, Application - Global Forecast to 2030 - Product Image

Stem Cell Therapy for Premature Ovarian Failure Market by Cell Type, Therapy Type, End User, Application - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Autologous Stem Cell & Non-Stem Cell Therapies Market by Therapy Type, Product Type, Indication, End User, Cell Source, Administration Route, Manipulation Level - Global Forecast to 2030 - Product Image

Autologous Stem Cell & Non-Stem Cell Therapies Market by Therapy Type, Product Type, Indication, End User, Cell Source, Administration Route, Manipulation Level - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Allogeneic Stem Cell Therapies, Autologous Stem Cell Therapies), By Therapeutic Application (Oncology), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Allogeneic Stem Cell Therapies, Autologous Stem Cell Therapies), By Therapeutic Application (Oncology), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Animal Stem Cell Therapy Market By Product Type, By Type of Stem Cells, By Application, Species, and End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035 - Product Image

Animal Stem Cell Therapy Market By Product Type, By Type of Stem Cells, By Application, Species, and End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

  • Report
  • 215 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.